HT
PTCT icon

HAP Trading’s PTC Therapeutics PTCT Stock Holding History

HAP Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,300
Closed -$16K – 1456
2019
Q4 		$16K Buy
+14,300
New +$608K ﹤0.01% 936
2018
Q2 		– Sell
-38,100
Closed -$34K – 1096
2018
Q1 		$34K Buy
+38,100
New +$965K ﹤0.01% 698
2017
Q4 		– Sell
-693,300
Closed -$77K – 1131
2017
Q3 		$77K Buy
+693,300
New +$13.6M ﹤0.01% 604
2017
Q2 		– Sell
-855,500
Closed -$297K – 1129
2017
Q1 		$297K Buy
+855,500
New +$10.4M 0.02% 417
2016
Q1 		– Sell
-34,100
Closed -$306K – 1006
2015
Q4 		$306K Buy
34,100
+23,900
+234% +$703K 0.01% 438
2015
Q3 		$358K Hold
10,200
– – 0.02% 424
2015
Q2 		$180K Buy
+10,200
New +$595K 0.01% 490

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

HAP Trading's PTCT Position: Q2 2017 in Review

HAP Trading sold out of PTC Therapeutics (PTCT) in Q2 2017, closing a stake of 101,707 shares — an estimated $1M sold.

HAP Trading first reported a position in PTCT in Q1 2017 and held it in 1 quarter. The position peaked at $1M in Q1 2017. 114 funds tracked by Wall St. Rank hold PTCT as of Q2 2017.

  • HAP Trading reported no remaining PTC Therapeutics position as of Q2 2017 after selling out during the quarter.
  • HAP Trading sold 101,707 PTC Therapeutics shares in Q2 2017, an estimated $1M.
  • HAP Trading first reported a position in PTC Therapeutics in Q1 2017 and held it in 1 quarter.
  • HAP Trading's PTC Therapeutics position peaked at $1M in Q1 2017.
  • 114 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.